Navigation Links
ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer

Lung cancer, the header among all forms of cancer, is avenged now by the new proven effective ZD1839.

It has been shown that ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, has confirmed, durable responses and safety in patients with advanced non-small cell lung cancer (NSCLC) as monotherapy and in combination with standard chemotherapy agents after segmental scrutinization in two different studies.

Vincent Miller, MD, of Memorial Sloan-Kettering Cancer Center in New York and the principal investigator of the first study said, "It is hoped that our study will be a prelude to better outcomes for NSCLC patients in the near future." No novel toxicities were seen with ZD1839 treatment in combination with standard chemotherapy.

In a second study, which addressed intermittent dosing of ZD1839 in Japanese patients with advanced lung cancer, more than 20% of patients showed partial responses to ZD1839 between 1 and 11 months.

With such promising results, researchers are now working on whether this drug can be used for other forms of cancer as well.
'"/>




Page: 1

Related medicine news :

1. Study Proves That MMR Vaccine Is Not Connected To Autistic Babies
2. Pilot Study Proves Home Abortions ‘Safe’
3. Many Nonprescription Cough Medicines Proves Ineffective
4. Less Invasive By Pass Surgery Proves Economical In The Long Run
5. Epidural Mistakes Proves To Be Fatal Blunders
6. Combined Anti-Fever Drug Therapy Proves Unsafe for Childhood Fever
7. Drug Trial Proves Nightmare for British Indian Student
8. Naturopathic Care Proves Beneficial for TMD Pain
9. Medtronic Device Proves Effective in Parkinson’s Diseas
10. Large Community Spirometry Screening Proves Successful
11. Pregabalin Proves Durable Pain Relief Option for Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2019)... ... 2019 , ... A Topping Out event was hosted today at the construction ... & Peterson Construction. The event celebrated reaching the final height of the structure set ... first of its kind in Texas, STA’s facility will be home to an organ ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Ralphs, QFC and Fred Meyer, King Sooper, Fry’s, Roundy’s, Smiths and Dillons. , ... grain-free & gluten-free. , “Ingredient purity and fresh taste is paramount for ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... for the Department of Veterans Affairs Community Care Referrals and Authorizations program. The ... the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by community ...
(Date:10/8/2019)... REY, Calif. (PRWEB) , ... October 08, 2019 ... ... for laboratory managers, administrators and pathologists, 4medica® President Gregg Church ... is the first-to-market solution reinventing labs orders management-by starting with the right, ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... biomimetic dentistry techniques, has recently attended an advanced Level III training in Cagliari, ... of dentistry. The training took place September 16-19, 2019 at the Sardinia Dental ...
Breaking Medicine News(10 mins):
(Date:10/8/2019)... ... October 08, 2019 , ... Respected dentist, Dr. Kenneth ... to enhance his skill and knowledge of dental implant diagnosis, placement and maintenance. ... four-part series of classes that combines in-depth lectures with hands-on workshops. Halfway through ...
(Date:10/8/2019)... ... October 08, 2019 , ... A free, interactive event ... month in Austin, Texas. The event, featuring thought leaders, innovators and health experts, will ... , Held from 2:00 p.m. to 5:30 p.m. CT on October 19 at the ...
(Date:10/8/2019)... ... October 08, 2019 , ... Catalent, the leading global ... therapies, and consumer health products, today announced that it will present at the ... on Oct. 15 – 19, 2019. , On Thursday, Oct. 17 at 2:30 ...
Breaking Medicine Technology: